annual total liabilities:
$966.35M-$6.13M(-0.63%)Summary
- As of today (May 29, 2025), BCRX annual total liabilities is $966.35 million, with the most recent change of -$6.13 million (-0.63%) on December 31, 2024.
- During the last 3 years, BCRX annual total liabilities has risen by +$271.22 million (+39.02%).
- BCRX annual total liabilities is now -0.63% below its all-time high of $972.49 million, reached on December 31, 2023.
Performance
BCRX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$931.97M-$34.38M(-3.56%)Summary
- As of today (May 29, 2025), BCRX quarterly total liabilities is $931.97 million, with the most recent change of -$34.38 million (-3.56%) on March 31, 2025.
- Over the past year, BCRX quarterly total liabilities has dropped by -$12.09 million (-1.28%).
- BCRX quarterly total liabilities is now -4.17% below its all-time high of $972.49 million, reached on December 31, 2023.
Performance
BCRX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
BCRX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.6% | -1.3% |
| 3 y3 years | +39.0% | +34.7% |
| 5 y5 years | +605.2% | +601.0% |
BCRX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.6% | +39.0% | -4.2% | +34.7% |
| 5 y | 5-year | -0.6% | +605.2% | -4.2% | +601.0% |
| alltime | all time | -0.6% | >+9999.0% | -4.2% | >+9999.0% |
BCRX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $931.97M(-3.6%) |
| Dec 2024 | $966.35M(-0.6%) | $966.35M(+0.7%) |
| Sep 2024 | - | $959.82M(+1.2%) |
| Jun 2024 | - | $948.02M(+0.4%) |
| Mar 2024 | - | $944.06M(-2.9%) |
| Dec 2023 | $972.49M(+15.1%) | $972.49M(+4.1%) |
| Sep 2023 | - | $933.91M(+1.7%) |
| Jun 2023 | - | $918.60M(+9.6%) |
| Mar 2023 | - | $838.02M(-0.8%) |
| Dec 2022 | $844.60M(+21.5%) | $844.60M(+5.4%) |
| Sep 2022 | - | $801.25M(+10.7%) |
| Jun 2022 | - | $723.77M(+4.6%) |
| Mar 2022 | - | $691.93M(-0.5%) |
| Dec 2021 | $695.14M(+96.4%) | $695.14M(+68.4%) |
| Sep 2021 | - | $412.81M(+7.7%) |
| Jun 2021 | - | $383.36M(+6.7%) |
| Mar 2021 | - | $359.42M(+1.5%) |
| Dec 2020 | $353.98M(+158.3%) | $353.98M(+148.2%) |
| Sep 2020 | - | $142.59M(+3.2%) |
| Jun 2020 | - | $138.20M(+4.0%) |
| Mar 2020 | - | $132.94M(-3.0%) |
| Dec 2019 | $137.03M(+40.4%) | $137.03M(+4.0%) |
| Sep 2019 | - | $131.75M(+5.0%) |
| Jun 2019 | - | $125.54M(+4.8%) |
| Mar 2019 | - | $119.83M(+22.8%) |
| Dec 2018 | $97.61M(+3.3%) | $97.61M(+2.3%) |
| Sep 2018 | - | $95.44M(+5.5%) |
| Jun 2018 | - | $90.46M(-3.1%) |
| Mar 2018 | - | $93.32M(-1.2%) |
| Dec 2017 | $94.49M(+7.1%) | $94.49M(+4.0%) |
| Sep 2017 | - | $90.86M(+1.6%) |
| Jun 2017 | - | $89.43M(-1.7%) |
| Mar 2017 | - | $90.98M(+3.1%) |
| Dec 2016 | $88.27M(+18.3%) | $88.27M(+0.9%) |
| Sep 2016 | - | $87.51M(+27.1%) |
| Jun 2016 | - | $68.83M(-8.3%) |
| Mar 2016 | - | $75.08M(+0.6%) |
| Dec 2015 | $74.64M(+21.9%) | $74.64M(-0.4%) |
| Sep 2015 | - | $74.91M(+1.1%) |
| Jun 2015 | - | $74.09M(+13.1%) |
| Mar 2015 | - | $65.50M(+7.0%) |
| Dec 2014 | $61.24M(+22.5%) | $61.24M(+14.1%) |
| Sep 2014 | - | $53.67M(+3.4%) |
| Jun 2014 | - | $51.89M(+5.7%) |
| Mar 2014 | - | $49.11M(-1.8%) |
| Dec 2013 | $49.99M(-13.6%) | $49.99M(+0.4%) |
| Sep 2013 | - | $49.80M(+1.7%) |
| Jun 2013 | - | $48.96M(-1.6%) |
| Mar 2013 | - | $49.74M(-14.1%) |
| Dec 2012 | $57.89M(-14.1%) | $57.89M(+6.6%) |
| Sep 2012 | - | $54.31M(-10.3%) |
| Jun 2012 | - | $60.58M(+6.4%) |
| Mar 2012 | - | $56.94M(-15.5%) |
| Dec 2011 | $67.40M(+53.4%) | $67.40M(+1.4%) |
| Sep 2011 | - | $66.47M(-3.9%) |
| Jun 2011 | - | $69.15M(+0.8%) |
| Mar 2011 | - | $68.60M(+56.1%) |
| Dec 2010 | $43.94M(-21.4%) | $43.94M(+18.8%) |
| Sep 2010 | - | $37.01M(+13.9%) |
| Jun 2010 | - | $32.49M(-17.0%) |
| Mar 2010 | - | $39.13M(-30.0%) |
| Dec 2009 | $55.92M | $55.92M(+51.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $37.04M(+10.9%) |
| Jun 2009 | - | $33.41M(-2.0%) |
| Mar 2009 | - | $34.09M(-10.9%) |
| Dec 2008 | $38.27M(-50.8%) | $38.27M(-40.5%) |
| Sep 2008 | - | $64.34M(-1.4%) |
| Jun 2008 | - | $65.23M(-12.9%) |
| Mar 2008 | - | $74.92M(-3.7%) |
| Dec 2007 | $77.81M(+64.4%) | $77.81M(+3.0%) |
| Sep 2007 | - | $75.55M(+9.4%) |
| Jun 2007 | - | $69.08M(+28.1%) |
| Mar 2007 | - | $53.92M(+13.9%) |
| Dec 2006 | $47.33M(+16.0%) | $47.33M(-5.7%) |
| Sep 2006 | - | $50.18M(+5.7%) |
| Jun 2006 | - | $47.49M(-3.1%) |
| Mar 2006 | - | $49.00M(+20.1%) |
| Dec 2005 | $40.81M(+1201.9%) | $40.81M(+989.1%) |
| Sep 2005 | - | $3.75M(+46.3%) |
| Jun 2005 | - | $2.56M(-14.1%) |
| Mar 2005 | - | $2.98M(-4.8%) |
| Dec 2004 | $3.13M(+90.1%) | $3.13M(-12.2%) |
| Sep 2004 | - | $3.57M(+51.3%) |
| Jun 2004 | - | $2.36M(-6.6%) |
| Mar 2004 | - | $2.52M(+53.2%) |
| Dec 2003 | $1.65M(+40.6%) | $1.65M(+15.2%) |
| Sep 2003 | - | $1.43M(-9.7%) |
| Jun 2003 | - | $1.58M(+33.5%) |
| Mar 2003 | - | $1.19M(+1.3%) |
| Dec 2002 | $1.17M(-48.7%) | $1.17M(-5.0%) |
| Sep 2002 | - | $1.23M(-25.9%) |
| Jun 2002 | - | $1.67M(-9.3%) |
| Mar 2002 | - | $1.83M(-19.6%) |
| Dec 2001 | $2.28M(-75.6%) | $2.28M(+107.5%) |
| Sep 2001 | - | $1.10M(-75.0%) |
| Jun 2001 | - | $4.40M(-44.4%) |
| Mar 2001 | - | $7.92M(-15.3%) |
| Dec 2000 | $9.35M(+367.3%) | $9.35M(+658.6%) |
| Sep 2000 | - | $1.23M(-32.4%) |
| Jun 2000 | - | $1.82M(+13.5%) |
| Mar 2000 | - | $1.61M(-19.7%) |
| Dec 1999 | $2.00M(+42.9%) | $2.00M(+33.3%) |
| Sep 1999 | - | $1.50M(+15.4%) |
| Jun 1999 | - | $1.30M(0.0%) |
| Mar 1999 | - | $1.30M(-7.1%) |
| Dec 1998 | $1.40M(+16.7%) | $1.40M(-22.2%) |
| Sep 1998 | - | $1.80M(+20.0%) |
| Jun 1998 | - | $1.50M(-11.8%) |
| Mar 1998 | - | $1.70M(+41.7%) |
| Dec 1997 | $1.20M(-29.4%) | $1.20M(-25.0%) |
| Sep 1997 | - | $1.60M(-11.1%) |
| Jun 1997 | - | $1.80M(+5.9%) |
| Mar 1997 | - | $1.70M(0.0%) |
| Dec 1996 | $1.70M(-5.6%) | $1.70M(+6.3%) |
| Sep 1996 | - | $1.60M(-15.8%) |
| Jun 1996 | - | $1.90M(+18.8%) |
| Mar 1996 | - | $1.60M(-11.1%) |
| Dec 1995 | $1.80M(+12.5%) | $1.80M(+38.5%) |
| Sep 1995 | - | $1.30M(-18.8%) |
| Jun 1995 | - | $1.60M(+14.3%) |
| Mar 1995 | - | $1.40M(-12.5%) |
| Dec 1994 | $1.60M | $1.60M(-5.9%) |
| Sep 1994 | - | $1.70M(-26.1%) |
| Jun 1994 | - | $2.30M(-8.0%) |
| Mar 1994 | - | $2.50M |
FAQ
- What is BioCryst Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual total liabilities year-on-year change?
- What is BioCryst Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly total liabilities year-on-year change?
What is BioCryst Pharmaceuticals annual total liabilities?
The current annual total liabilities of BCRX is $966.35M
What is the all time high annual total liabilities for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual total liabilities is $972.49M
What is BioCryst Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, BCRX annual total liabilities has changed by -$6.13M (-0.63%)
What is BioCryst Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of BCRX is $931.97M
What is the all time high quarterly total liabilities for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly total liabilities is $972.49M
What is BioCryst Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, BCRX quarterly total liabilities has changed by -$12.09M (-1.28%)